about
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific T...
Read More
2.29
0.33
(16.84%)
437.3K
XNAS Volume
XNAS 28 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Immix Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..